Registered lobbyist
Amy Prentice
AstraZeneca Pharmaceuticals, LP · 410-456-5210 · on file 2022 to 2026
Clients on file
1
1 in Nov 2025 - Oct 2026
Reported compensation
$9,856
all years on file
Bills testified on
5
4 for · 1 against · 0 info
Got their outcome
80%
4 of 5 decided bills
Who they are and whom they represent
AI profiles turn on once ANTHROPIC_API_KEY is set on the server.
Testimony on record
2026 Regular Session2 appearances
| Bill | Position | Appearing for | Outcome |
|---|---|---|---|
| HB 484 Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising | UNF | AstraZeneca | Did not advance |
| SB 773 Health Occupations - Pharmacists - Vaccination Orders | FAVPDF | AstraZeneca | Enacted |
2025 Regular Session2 appearances
| Bill | Position | Appearing for | Outcome |
|---|---|---|---|
| HB 49 Environment - Building Energy Performance Standards - Alterations and Analysis | FWAPDF | AstraZeneca | Enacted |
| SB 256 Environment - Building Energy Performance Standards - Compliance and Reporting | FWAPDF | AstraZeneca | Did not advance |
2023 Regular Session1 appearances
| Bill | Position | Appearing for | Outcome |
|---|---|---|---|
| SB 805 Maryland Medical Assistance Program and Health Insurance – Required Coverage for Biomarker Testing | FAV | AstraZeneca | Enacted |